Earnings Feed
Start Free
Home/Filings/4/0001144204-13-002711
4//SEC Filing

HARRIS ROBERT LEWIS 4

Accession 0001144204-13-002711

CIK 0001424812other
View on SEC.govCompany Profile

Filed

Jan 15, 7:00 PM ET

Accepted

Jan 16, 9:30 PM ET

Size

20.5 KB

Accession

0001144204-13-002711

Insider Transaction Report

Form 4
Period: 2010-12-13
AMARANTUS BIOSCIENCE, INC.AMBS
HARRIS ROBERT LEWIS
Director
Transactions
  • Purchase

    Common Stock

    2013-01-14$0.10/sh+50,000$4,900→ 1,394.332 total
  • Award

    5% Convertible Preferred Stock

    2012-07-15+31,250→ 6,961,541 total
    Exercise: $1.50→ Common Stock (1,562,500 underlying)
  • Award

    Convertible Series B Preferred Stock

    2012-07-15$0.00/sh+31,250$31→ 31,250 total
  • Award

    Convertible Note

    2010-12-13$50000.00/sh+1$50,000→ 2,761,986 total
    Exercise: $0.04→ Common Stock (2,761,986 underlying)
  • Award

    5% Convertible Preferred Stock

    2012-11-04+100,000→ 11,961,541 total
    Exercise: $1.50→ Common Stock (5,000,000 underlying)
  • Award

    Convertible Note

    2010-04-27$100000.00/sh+1$100,000→ 4,119,863 total
    Exercise: $0.04→ Common Stock (1,357,877 underlying)
  • Award

    Convertible Note

    2011-08-27$50000.00/sh+1$50,000→ 5,399,041 total
    Exercise: $0.04→ Common Stock (1,279,178 underlying)
  • Purchase

    Common Stock

    2012-07-26$0.01/sh+7,000$105→ 1,344,332 total
  • Award

    Convertible Series B Preferred Stock

    2012-11-04$0.00/sh+100,000$100→ 131,250 total
Footnotes (3)
  • [F1]No specific date set.
  • [F2]Set based upon current price, actual price will be determine on the date of conversion.
  • [F3]N/A

Documents

1 file

Issuer

AMARANTUS BIOSCIENCE, INC.

CIK 0001424812

→
Entity typeother

Related Parties

1
  • filerCIK 0001567140

Filing Metadata

Form type
4
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 9:30 PM ET
Size
20.5 KB
View on SEC.gov